The test was developed in collaboration with Eli Lilly and can be used with other clinical information to rule out Alzheimer's disease as the cause of cognitive decline.

A multi-centre, prospective trial involving 787 subjects across Australia, Europe, and the US formed the basis for the CE ...

Real-world data presented at the 2025 International Conference on Malignant Lymphoma (ICML) has provided new insights into the use of clonoSEQ, a circulating tumour DNA (ctDNA) ...

A new test called PAC-MANN is designed to detect signs of pancreatic cancer in blood. It's still in development, but the hope is that it will help catch the deadly cancer early.

Researchers discovered that patients with pollinosis received markedly different results depending on which specific ...

Researchers have developed an open-source molecular diagnostic assay for pathogen detection, successfully tested for COVID-19 ...

Astute Analytica stands out as a premier provider of comprehensive Automated Immunoassay Analyzers market research reports specifically tailored for the healthcare sector. Our commitment lies in ...

We develop and present a one-pot sandwich immunoassay (termed oneSTEP) to detect target biomolecules in complex biological fluids based on programmable zwitterionic polymer coacervates. We design ...

Leica Biosystems has partnered with Molecular Instruments (MI) to integrate its imaging assay with Leica’s BOND series of research staining systems. MI’s Highly sensitive Chromogenic RNA in situ ...

Anbio has introduced the Anbio AF-100S fluorescent immunoassay (FIA) solution to assist healthcare professionals in providing better care for their patients. The handheld point-of-care ...